Notifications
Back

So Every Drug Reaches Its Target

Moogene Medi designs lipid nanoparticles (LNP) around the properties of each drug and develops the technology to deliver it where it needs to go.

Research Capabilities

0countries

Patents registered

Korea, U.S., China, Australia and more

0papers

SCI-class publications

CEO's record

0projects

Government-funded R&D projects

LNP Platform

mRNA, small molecules, proteins and gene-editing payloads differ in size and stability. We design the lipid composition and particle structure to match each one.

mRNA LNP Platform
mRNA
Small Molecules LNP Platform
Small Molecules
Proteins LNP Platform
Proteins
Gene Editing LNP Platform
Gene Editing

LNP-Chemicals Turning a Pill
into a Topical

Same efficacy, with less systemic exposure and fewer side effects.

World's first topical hair-loss treatment

Topical
Dutasteride

We reformulated an oral androgenetic alopecia treatment into a topical applied to the scalp.

By designing a DDS that reaches the hair-follicle cells, we minimize the side effects of scalp application and aim to replace oral dosing.

Key preclinical results

Delivery efficiency

At 1/10 the oral dose, delivery efficiency comparable to the oral group

Systemic exposure

Blood drug concentration was near-undetectable in every topical group—about 1/100 of oral levels, suggesting fewer side effects

Development status

06 ITEMS
Active ingredient
Dutasteride 0.25 mg/mL
Dosage form
Suspension for topical application
Indication
Androgenetic alopecia (prescription drug)
Clinical stage
IND approved · Phase 1/2a ongoing as of 2026
Co-development
Agreements signed with four pharmaceutical companies
Patents
Patents held on LNP-Chemicals compositions

LNP-mRNA Made at the Point of Care,
Without a Cold Chain

Conventional mRNA vaccines are formulated into LNP at the plant and shipped ultra-cold. Moogene Medi reordered the process to enable room-temperature storage and on-site preparation.

Conventional mRNA vaccine

-70°C
  1. LNP manufacturing

    1–2 weeks

  2. Cold-chain shipping

    2–3 weeks

  3. Administration

Moogene Medi

25°C
  1. Lipid cake

    room-temperature storage

  2. Mix with mRNA on site
  3. Immediate administration
  1. 01

    The lipids are formed into a cake and stored at 25°C. At the point of care they are mixed with mRNA to make the injectable.

  2. 02

    With no need for costly equipment or ultra-cold logistics, production and distribution costs fall and disease-specific vaccines can be made quickly.

Consistent quality

Quality

Quality equivalent to conventional manufacturing (particle size, PDI, encapsulation efficiency)

Enhanced delivery efficiency

Delivery efficiency

Superior in vitro transfection versus conventional manufacturing (HeLa, 24 h, Fluc mRNA 2 µg/mL)

Target organ-specific delivery

Organ-selective delivery

We design LNP that reach the target organ selectively, enabling disease-specific mRNA delivery vehicles.

Microbubble Ultrasound Opens the Skin Barrier

Ultrasound bursts the microbubbles, briefly opening the skin barrier so actives pass through. Delivery by application alone—no needle.

Ultrasound

Bubble burst

Skin barrier opens

Active penetrates

0–0×

Skin permeation

Skin permeation of the active increases 10–15× when the ultrasound device is used

World's first

Commercialization

The world's first microbubble-formulated cosmetic / dual-function: brightening and anti-wrinkle

Before ultrasound
US flash Cavitation Bubbleburst POP
Intracellular delivery(<1 min)
Before ultrasound After ultrasound

Ultrasound bursts the microbubbles to open a temporary path through the skin barrier, helping the actives get through.

Cosmetic LNP Functional Actives,
Delivered Inside an LNP

We solubilize lipophilic actives in LNP to raise skin absorption and stability—and formulate them without alcohol.

0×

Skin delivery efficiency

Higher skin absorption of the active

Solubilization

Lipophilic actives formulated without alcohol

Stability

Improved stability and spreadability of the active

REGENERATION

Ceramide-24 LNP

Using our proprietary technology for solubilizing lipophilic compounds, we confirmed a regenerative effect greater than that of the protein biologic EGF.

0%

Cell growth promotion

Patent registered

Ingredient formulation technology

Published in a peer-reviewed journal

Regenerative effect confirmed

Cosmetic Ingredients

Our LNP ingredients, organized by function: hair loss, wrinkles, regeneration, brightening, slimming and anti-inflammation.

01

DAO LNP

Diaminopyrimidine Oxide

Function
Hair growth promotion · minoxidil derivative
Application
Shampoo · hair tonic · ampoule
02

AHP8 LNP

Acetyl Hexapeptide-8

Function
Wrinkle improvement · firmness
Application
Serum · cream · sheet mask
03

Cera LNP

Ceramide NP

Function
Barrier strengthening · moisturization
Application
Cream · serum · lotion
04

NA LNP

Niacinamide

Function
Brightening · wrinkles · anti-inflammation
Application
Serum · cream
05

DCA LNP

Deoxycholic Acid

Function
Slimming · body contouring
Application
Body cream · gel
06

Phyto LNP

Phytosphingosine

Function
Anti-inflammation · barrier strengthening
Application
Cream · serum
07

Tranexamic acid LNP

Tranexamic Acid

Function
Melasma · redness relief
Application
Cream · serum
08

4-Butyl resorcinol LNP

4-Butyl Resorcinol

Function
Melanin synthesis inhibition
Application
Cream · serum
09

α-tocopherol LNP

α-Tocopherol

Function
Antioxidant · moisturization
Application
Sunscreen · balm
10

β-sitosterol LNP

β-Sitosterol

Function
Brightening · soothing · hair growth
Application
Shampoo · hair tonic
11

Bakuchiol LNP

Bakuchiol

Function
Gentle anti-aging · retinol alternative
Application
Cream · serum